BriaCell Therapeutics Corp. Annual Net Cash Provided by (Used in) Investing Activities in USD for 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
BriaCell Therapeutics Corp. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate for 2024.
  • BriaCell Therapeutics Corp. Net Cash Provided by (Used in) Investing Activities for the quarter ending October 31, 2024 was -$75K.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$682K Aug 1, 2023 Jul 31, 2024 10-K 2024-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.